E

Eyenovia
D

EYEN

0.10610
USD
0.00
(0.95%)
Market Closed
Volume
526,333
EPS
-1
Div Yield
-
P/E
-0
Market Cap
9,171,455
OverviewSignalsIdeasNews
Related Instruments
    IDEXUSD
    IDEXUSD
    0.007635
    (14.01%)
    0.054480 USD
    IDEXBUSD
    IDEXBUSD
    -0.000535
    (-1.08%)
    0.048810 USD
    AAPL
    AAPL
    -3.130
    (-1.37%)
    229.75 USD
    AMZN
    AMZN
    -8.930
    (-4.22%)
    197.06 USD
    GOOGL
    GOOGL
    -3.110
    (-1.77%)
    164.75 USD
    I
    IDEX
    0
    (0%)
    0.000000 USD
    N
    NIO
    0.06500
    (1.47%)
    4.49500 USD
    S
    SNDL
    0.00500
    (0.26%)
    1.95500 USD
    TSLA
    TSLA
    9.69
    (3.11%)
    352.65 USD
    More
News

Title: Eyenovia

Sector: Healthcare
Industry: Biotechnology
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.